360 related articles for article (PubMed ID: 22796154)
1. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
Diab Vasc Dis Res; 2013 Mar; 10(2):143-51. PubMed ID: 22786872
[TBL] [Abstract][Full Text] [Related]
3. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
Wannamethee SG; Lennon L; Shaper AG
Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
[TBL] [Abstract][Full Text] [Related]
4. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus.
Sluik D; Beulens JW; Weikert C; van Dieren S; Spijkerman AM; van der A DL; Fritsche A; Joost HG; Boeing H; Nöthlings U
Diabetes Metab Res Rev; 2012 Mar; 28(3):284-8. PubMed ID: 22144398
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study.
Yi SW; Lee SH; Hwang HJ; Yi JJ
Atherosclerosis; 2017 Oct; 265():102-109. PubMed ID: 28881267
[TBL] [Abstract][Full Text] [Related]
8. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
9. gamma-Glutamyltransferase predicts cardiovascular death among Japanese women.
Hozawa A; Okamura T; Kadowaki T; Murakami Y; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Okayama A; Ueshima H;
Atherosclerosis; 2007 Oct; 194(2):498-504. PubMed ID: 17034795
[TBL] [Abstract][Full Text] [Related]
10. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
11. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
12. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
[TBL] [Abstract][Full Text] [Related]
13. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies.
Du G; Song Z; Zhang Q
Prev Med; 2013 Jul; 57(1):31-7. PubMed ID: 23571185
[TBL] [Abstract][Full Text] [Related]
14. γ-Glutamyl Transferase as a Risk Factor for All-Cause or Cardiovascular Disease Mortality Among 5912 Ischemic Stroke.
Tu WJ; Liu Q; Cao JL; Zhao SJ; Zeng XW; Deng AJ
Stroke; 2017 Oct; 48(10):2888-2891. PubMed ID: 28904238
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes.
Wannamethee G; Ebrahim S; Shaper AG
Am J Epidemiol; 1995 Oct; 142(7):699-708. PubMed ID: 7572939
[TBL] [Abstract][Full Text] [Related]
16. Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.
Park WY; Koh ES; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
PLoS One; 2015; 10(9):e0138159. PubMed ID: 26376075
[TBL] [Abstract][Full Text] [Related]
17. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
[TBL] [Abstract][Full Text] [Related]
18. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.
Morling JR; Fallowfield JA; Williamson RM; Robertson CM; Glancy S; Guha IN; Strachan MW; Price JF
Diabetologia; 2015 Jul; 58(7):1484-93. PubMed ID: 25820150
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.
Strasak AM; Kelleher CC; Klenk J; Brant LJ; Ruttmann E; Rapp K; Concin H; Diem G; Pfeiffer KP; Ulmer H;
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1857-65. PubMed ID: 18617645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
